Conversation with The Cancer LetterFree A $250M gift creates Break Through Cancer foundation to focus five cancer centers on hard-to-treat diseases February 25, 2021Vol.47 No.08By Matthew Bin Han Ong and Paul Goldberg
FreeTrials & Tribulations City of Hope leads Cancer Patients Bill of Rights resolution, aimed at expanding access to unleash the full benefits of cancer care innovation February 19, 2021Vol.47 No.07By Harlan Levine and Joseph Alvarnas
Black History MonthFreeGuest Editorial Remembering Jane Cooke Wright, a Black woman physician, who was among seven founders of ASCO February 19, 2021Vol.47 No.07By Edith P. Mitchell
FreeIn the Archives Black History Month, the National Cancer Act—and opening up the archives February 05, 2021Vol.47 No.05
Drugs & TargetsFree FDA grants accelerated approval to Tepmetko for metastatic NSCLC February 05, 2021Vol.47 No.05
Drugs & TargetsFree Keytruda receives positive EU CHMP opinion for expanded approval in some cases of relapsed or refractory classical hodgkin Lymphoma February 05, 2021Vol.47 No.05
Clinical RoundupFree More than half of cancer survivors have underlying medical conditions associated with severe COVID-19 February 05, 2021Vol.47 No.05
Clinical RoundupFree Gene mutations linked to worse outcomes from leukemia in Hispanic and Latino children February 05, 2021Vol.47 No.05